123 related articles for article (PubMed ID: 18726574)
41. Fluorine--a new element in the design of membrane-active peptides.
Marsh EN; Buer BC; Ramamoorthy A
Mol Biosyst; 2009 Oct; 5(10):1143-7. PubMed ID: 19756303
[TBL] [Abstract][Full Text] [Related]
42. Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptides.
Trepel M; Pasqualini R; Arap W
Methods Enzymol; 2008; 445():83-106. PubMed ID: 19022056
[TBL] [Abstract][Full Text] [Related]
43. Purification, characterization and cloning of two novel tigerinin-like peptides from skin secretions of Fejervarya cancrivora.
Song Y; Lu Y; Wang L; Yang H; Zhang K; Lai R
Peptides; 2009 Jul; 30(7):1228-32. PubMed ID: 19540421
[TBL] [Abstract][Full Text] [Related]
44. Peptidomimetics and small-molecule drug design: towards improved bioavailability and in vivo stability.
Beeley N
Trends Biotechnol; 1994 Jun; 12(6):213-6. PubMed ID: 7765066
[No Abstract] [Full Text] [Related]
45. How do you find new drugs using polypeptide display?
Jermutus L; Osborn JK
Trends Biotechnol; 2000 Jul; 18(7):280-1. PubMed ID: 10950509
[No Abstract] [Full Text] [Related]
46. Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum.
Böttger R; Hoffmann R; Knappe D
PLoS One; 2017; 12(6):e0178943. PubMed ID: 28575099
[TBL] [Abstract][Full Text] [Related]
47. Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs.
Nguyen LT; Chau JK; Perry NA; de Boer L; Zaat SA; Vogel HJ
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844765
[TBL] [Abstract][Full Text] [Related]
48. Investigation of peptide biomarker stability in plasma samples using time-course MS analysis.
Yi J; Liu Z; Gelfand CA; Craft D
Methods Mol Biol; 2011; 728():161-75. PubMed ID: 21468947
[TBL] [Abstract][Full Text] [Related]
49. Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum.
Powell MF; Stewart T; Otvos L; Urge L; Gaeta FC; Sette A; Arrhenius T; Thomson D; Soda K; Colon SM
Pharm Res; 1993 Sep; 10(9):1268-73. PubMed ID: 8234161
[TBL] [Abstract][Full Text] [Related]
50. Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization.
Gentilucci L; De Marco R; Cerisoli L
Curr Pharm Des; 2010; 16(28):3185-203. PubMed ID: 20687878
[TBL] [Abstract][Full Text] [Related]
51. Improving the serum stability of site-specific antibody conjugates with sulfone linkers.
Patterson JT; Asano S; Li X; Rader C; Barbas CF
Bioconjug Chem; 2014 Aug; 25(8):1402-7. PubMed ID: 25099687
[TBL] [Abstract][Full Text] [Related]
52. Stability of amyloid-β peptides in plasma and serum.
Bibl M; Welge V; Esselmann H; Wiltfang J
Electrophoresis; 2012 Feb; 33(3):445-50. PubMed ID: 22287174
[TBL] [Abstract][Full Text] [Related]
53. The future of peptide-based drugs.
Craik DJ; Fairlie DP; Liras S; Price D
Chem Biol Drug Des; 2013 Jan; 81(1):136-47. PubMed ID: 23253135
[TBL] [Abstract][Full Text] [Related]
54. Improved protease stability of the antimicrobial peptide Pin2 substituted with D-amino acids.
Carmona G; Rodriguez A; Juarez D; Corzo G; Villegas E
Protein J; 2013 Aug; 32(6):456-66. PubMed ID: 23925670
[TBL] [Abstract][Full Text] [Related]
55. Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy.
Akcan M; Stroud MR; Hansen SJ; Clark RJ; Daly NL; Craik DJ; Olson JM
J Med Chem; 2011 Feb; 54(3):782-7. PubMed ID: 21210710
[TBL] [Abstract][Full Text] [Related]
56. A synthetic glucagon-like peptide-1 analog with improved plasma stability.
Ritzel U; Leonhardt U; Ottleben M; Rühmann A; Eckart K; Spiess J; Ramadori G
J Endocrinol; 1998 Oct; 159(1):93-102. PubMed ID: 9795346
[TBL] [Abstract][Full Text] [Related]
57. A phage-displayed disulfide constrained peptide discovery platform yields novel human plasma protein binders.
Gao X; Kaluarachchi H; Zhang Y; Hwang S; Hannoush RN
PLoS One; 2024; 19(3):e0299804. PubMed ID: 38547072
[TBL] [Abstract][Full Text] [Related]
58. Development and evaluation of RADA-PDGF2 self-assembling peptide hydrogel for enhanced skin wound healing.
Deptuła M; Sawicka J; Sass P; Sosnowski P; Karpowicz P; Zawrzykraj M; Wardowska A; Tymińska A; Dzierżyńska M; Pietralik-Molińska Z; Peplińska B; Zieliński J; Kondej K; Kozak M; Sachadyn P; Rodziewicz-Motowidło S; Pikuła M
Front Pharmacol; 2023; 14():1293647. PubMed ID: 38094895
[No Abstract] [Full Text] [Related]
59. Structural and biological characterization of shortened derivatives of the cathelicidin PMAP-36.
Biondi B; de Pascale L; Mardirossian M; Di Stasi A; Favaro M; Scocchi M; Peggion C
Sci Rep; 2023 Sep; 13(1):15132. PubMed ID: 37704689
[TBL] [Abstract][Full Text] [Related]
60. Novel β-Hairpin Peptide from Marine Polychaeta with a High Efficacy against Gram-Negative Pathogens.
Safronova VN; Bolosov IA; Kruglikov RN; Korobova OV; Pereskokova ES; Borzilov AI; Panteleev PV; Ovchinnikova TV
Mar Drugs; 2022 Aug; 20(8):. PubMed ID: 36005520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
